文献速递肾小球疾病遗传性与小管间质肾病

APOL1特异性抗体揭示足细胞内源性APOL1定位于内质网和质膜

Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes.
PubMed 文献 · J Am Soc Nephrol · 2020-08-06

本研究利用新型APOL1特异性单克隆抗体,通过免疫组化、共聚焦和免疫电镜及足细胞分离技术,明确内源性及转染的APOL1异构体vA和vB1定位于内质网腔面和细胞表面,而非线粒体、内体或脂滴。APOL2及APOL1的vB3和大部分vC则定位于内质网胞质面且不在细胞表面。APOL1敲除足细胞无染色,证实抗体特异性,且G0、G1、G2变异体定位无差异。

要点

  • 内源性足细胞APOL1定位于内质网腔面和质膜。
  • APOL2及APOL1的vB3和vC异构体定位于内质网胞质面。
  • APOL1-G0、G1、G2变异体亚细胞定位无差异。

核心结论

  • APOL1存在于内质网和质膜,支持内质网应激或表面阳离子通道模型。
  • APOL1变异体的表面定位可能为治疗提供新靶点。

研究设计与样本

  • 使用新型APOL1特异性小鼠和兔单克隆抗体,通过免疫组化、共聚焦和免疫电镜及足细胞分离技术定位内源性和转染的APOL1。

主要发现

  • 内源性足细胞和转染的APOL1异构体vA和vB1(及少量vC)定位于内质网腔面和细胞表面,不位于线粒体、内体或脂滴。
  • APOL2、APOL1异构体vB3和大部分vC定位于内质网胞质面,不在细胞表面。
  • APOL1敲除足细胞无APOL1染色,证实抗体特异性。
  • 稳定再转染敲除足细胞诱导型APOL1-G0、G1、G2后,各变异体定位无差异。

临床怎么用

  • APOL1定位于质膜为靶向治疗提供了潜在新途径。

局限性

  • 既往免疫定位研究使用过表达蛋白或与APOL2交叉反应的抗体,本研究采用特异性抗体克服此局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: APOL1 is found in human kidney podocytes and endothelia. Variants G1 and G2 of the APOL1 gene account for the high frequency of nondiabetic CKD among African Americans. Proposed mechanisms of kidney podocyte cytotoxicity resulting from APOL1 variant overexpression implicate different subcellular compartments. It is unclear where endogenous podocyte APOL1 resides, because previous immunolocalization studies utilized overexpressed protein or commercially available antibodies that crossreact with APOL2. This study describes and distinguishes the locations of both APOLs. METHODS: Immunohistochemistry, confocal and immunoelectron microscopy, and podocyte fractionation localized endogenous and transfected APOL1 using a large panel of novel APOL1-specific mouse and rabbit monoclonal antibodies. RESULTS: Both endogenous podocyte and transfected APOL1 isoforms vA and vB1 (and a little of isoform vC) localize to the luminal face of the endoplasmic reticulum (ER) and to the cell surface, but not to mitochondria, endosomes, or lipid droplets. In contrast, APOL2, isoform vB3, and most vC of APOL1 localize to the cytoplasmic face of the ER and are consequently absent from the cell surface. APOL1 knockout podocytes do not stain for APOL1, attesting to the APOL1-specificity of the antibodies. Stable re-transfection of knockout podocytes with inducible APOL1-G0, -G1, and -G2 showed no differences in localization among variants. CONCLUSIONS: APOL1 is found in the ER and plasma membrane, consistent with either the ER stress or surface cation channel models of APOL1-mediated cytotoxicity. The surface localization of APOL1 variants potentially opens new therapeutic targeting avenues.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Scales SJ, Gupta N, De Mazière AM, et al. Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes. J Am Soc Nephrol. 2020. PMID: 32764142. doi:10.1681/ASN.2019080829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。